Food and Drug Administration (FDA) approved a generic version of Saxenda, a commonly prescribed glucagon-like peptide-1 receptor agonist (GLP-1)
For the best results, a comprehensive approach is emphasized, which combines medication with healthy lifestyle changes, including nutrition counseling and increased physical activity
Although weight loss injectables are not directly associated with DVT, its use in patients with multiple risk factors for clotting disorders, such as obesity or prolonged immobility, may increase that risk unnecessarily
In these scenarios, we want to rule out other causes, not just blame everything on the medication
Theyre often talked about as game-changers for diabetes management and weight loss
Our Concerns About Pendulum's Marketing Our main issue with the way Pendulum is currently marketing this supplement relates to the suggestion that this supplement increases GLP-1 levels